InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Kalin Katherine Bach. Officer active across 1 company, notably SELLAS Life Sciences Group, Inc.. Cumulatively, 4 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €32k. Activity tracked since 2 February 2023. The latest transaction was filed on 22 May 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
4 of 4 declarations